Tess Lombard
Internal Medicine · Waterbury, CTNPI 1710999198
Payments from drug & device makers
Across 120 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$425
- AbbVie$318
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$222
- Lilly USA, LLC$179
- Boehringer Ingelheim$174
- Bayer$167
- plus $881 from 18 others
What the payments were for
- Food & beverage$2,366100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $425 |
| AbbVie | 12 | $318 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $222 |
| Lilly USA, LLC | 12 | $179 |
| Boehringer Ingelheim | 10 | $174 |
| Bayer | 6 | $167 |
| Johnson & Johnson(2 entities) | 9 | $163 |
| Pfizer | 6 | $117 |
| Exact Sciences | 6 | $105 |
| Amgen | 5 | $82 |
| Redhill Biopharma Inc. | 5 | $80 |
| Alkermes, Inc. | 2 | $43 |
| Bausch Health US, LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Novartis | 2 | $30 |
| AstraZeneca | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Theratechnologies Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $23 |
| Mannkind Corporation | 1 | $20 |
| Medtronic | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Viiv Healthcare Company | 1 | $16 |
How this compares
$2,366 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $57,157 |
| JanuviaSitagliptin Phosphate | 41 | $56,971 |
| JardianceEmpagliflozin | 37 | $39,895 |
| TrulicityDulaglutide | 34 | $35,924 |
| TradjentaLinagliptin | 23 | $32,230 |
| RybelsusSemaglutide | 13 | $12,663 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $12,444 |
| LinzessLinaclotide | 11 | $11,138 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $7,752 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,137 |
| Epinephrine | 20 | $4,381 |
| Levemir FlexpenInsulin Detemir | 27 | $3,967 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $2,920 |
| Atorvastatin Calcium | 277 | $2,019 |
| Lidocaine | 20 | $1,966 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $174 | $72,12560 claims |
| Novo NordiskOzempic, Rybelsus | $425 | $69,82057 claims |
| Lilly USA, LLCTrulicity | $179 | $35,92434 claims |
| AbbVieLinzess | $318 | $11,13811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Waterbury
- Joseph SouferWaterbury$21.5M
- Elie HelouWaterbury$184K
- Oltjon AlbajramiWaterbury$57K
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.